Eris Lifesciences Ltd Q1 FY24 consolidated net profit higher at Rs. 94.85 crores

Eris Lifesciences Limited has reported Consolidated financial results for the period ended June 30, 2023.

Financial Results (Q1 FY2024) - QoQ Comparison

The company has reported total income of Rs. 467.611 crores during the period ended June 30, 2023 as compared to Rs. 403.802 crores during the period ended March 31, 2023.

The company has posted net profit / (loss) of Rs. 94.855 crores for the period ended June 30, 2023 as against net profit / (loss) of Rs. 65.418 crores for the period ended March 31, 2023.

The company has reported EPS of Rs. 6.97 for the period ended June 30, 2023 as compared to Rs. 4.79 for the period ended March 31, 2023.

Financials	Q1 FY2024	Q4 FY2023	% Change
Total Income	₹ 467.611 crs	₹403.802 crs	15.80%
Net Profit	₹94.855 crs	₹65.418 crs	45.00%
EPS	₹6.97	₹4.79	45.51%

Financial Results (Q1 FY2024) - YoY Comparison

The company has reported total income of Rs. 467.611 crores during the period ended June 30, 2023 as compared to Rs.401.321 crores during the period ended June 30, 2022.

The company has posted net profit / (loss) of Rs.94.855 crores for the period ended June 30, 2023 as against net profit / (loss) of Rs.94.577 crores for the period ended June 30, 2022.

The company has reported EPS of Rs.6.97 for the period ended June 30, 2023 as compared to Rs.6.95 for the period ended June 30, 2022.

Financials	Q1 FY2024	Q1 FY2023	% Change
Total Income	₹ 467.611 crs	₹401.321 crs	16.52%
Net Profit	₹94.855 crs	₹94.577 crs	0.29%
EPS	₹6.97	₹6.95	0.29%

Shares of Eris Lifesciences Limited was last trading in BSE at Rs. 824.85 as compared to the previous close of Rs. 800.35. The total number of shares traded during the day was 53604 in over 8098 trades.

The stock hit an intraday high of Rs. 838.00 and intraday low of 808.45. The net turnover during the day was Rs. 44194998.00.

Source : Equity Bulls

Keywords

ErisLifesciences Q1FY24 ResultUpdate